Scoopfeeds — Intelligent news, curated.
BofA raises argenx stock price target to $1,088 on myositis data
business

BofA raises argenx stock price target to $1,088 on myositis data

Investing.com · Jul 1, 2026, 9:22 PM · Also reported by 2 other sources

BofA raises argenx stock price target to $1,088 on myositis data

Read full story on Investing.com → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop